I received the following notice from Centerwatch :
--------- Forwarded message ----------
From: CenterWatch Patient Notification Service <[log in to unmask]>
Date: Sat, 13 Oct 2001 05:41:17 -0500
Subject: CenterWatch Email Notification Service
This e mail is being sent to notify you that the following new clinical
trial(s) in your selected area(s) of interest and geographic location(s)
have been recently posted on the CenterWatch web site at
http://www.centerwatch.com.
1) Parkinson's Disease. This study is being conducted in:
- Atlanta, GA
(http://www.centerwatch.com/patient/studies/stu29693.html)
- Philadelphia, PA
(http://www.centerwatch.com/patient/studies/stu29718.html)
-------------------------------------------------------------------------
---------------------------------
NOTE: The following is the only info. about these studies that was
available on the Centerwatch website.
Linda
<<Parkinson's Disease
Parkinson’s Disease affects up to 1.5 million Americans. Due to the
general need for new, more effective medications to treat the disease
with fewer side effects, there are many new medications being studied. If
you have been diagnosed with Parkinson’s disease, you may be eligible to
participate in a clinical research study. Some currently enrolling
studies allow participants to remain on their present medication.
Qualified participants will receive study-related medication,
study-related physical exams and compensation for time and travel
ICSL Clinical Studies, Atlanta
6065 Roswell Road
Suite 820
Atlanta, GA 30328
Telephone: 404-459-6699
Fax: 404-459-6524
Email: [log in to unmask]
ICSL Clinical Studies, Philadelphia
400 Market Street
Suite 425
Philadelphia, PA 19106
Telephone: 888-RX-TREAT
Fax: 215-923-5434
Email: [log in to unmask] >>
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
